Esteve Healthcare’s Acquisition of Pharma Rare Diseases Business From Perrigo

Laura Testa
Tagged:

Wachtell, Lipton, Rosen & Katz advised Perrigo, while Clifford Chance advised ESTEVE on the deal.Perrigo Company plc (NYSE: PRGO) announced that pharmaceutical company Esteve Healthcare, S.L….

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here